查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1709493

远端癫痫市场，按组件、按技术、按癫痫类型、按交付模式、按最终用户、按国家和地区划分 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Tele-epilepsy Market, By Component, By Technology, By Epilepsy Type, By Delivery Mode, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年远程癫痫市场规模价值 4.829 亿美元，2025 年至 2032 年的复合年增长率为 15.99%。

远程癫痫市场-市场动态

增强远端护理存取和人工智慧驱动的监控，以加速远端癫痫市场的成长。

远程癫痫市场正在显着扩张，这主要归功于数位健康解决方案的日益普及。美国疾病管制与预防中心 (CDC) 强调远距患者监测对包括癫痫在内的慢性病患者的重要性，以改善患者的治疗效果。美国食品药物管理局 (FDA) 已批准数种用于癫痫发作检测的可穿戴设备，这表明该技术在癫痫管理领域的接受度日益提高。例如，退伍军人健康管理局 (VHA) 已试行使用远距医疗平台为患有癫痫的退伍军人提供神经​​系统护理的项目，结果显示患者的出行时间减少了约 30%。美国国家神经疾病和中风研究所 (NINDS) 支持可远端分析脑电图资料的人工智慧演算法的研究，从而可以更及时、更准确地诊断和管理癫痫发作。

远程癫痫市场—关键洞察

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 15.99%

根据组件细分，预计软体将在 2024 年占据最大市场份额

根据技术细分，即时（同步）技术将成为 2024 年的领先技术

根据癫痫类型细分，局部性癫痫是 2024 年最主要的癫痫类型

根据交付模式细分，云端交付模式是 2024 年的主要交付模式

根据最终用户细分，医院是 2024 年的主要最终用户

按地区划分，北美是 2024 年的主要收入来源

远程癫痫市场細項分析：

全球远端癫痫市场根据组件、技术、癫痫类型、交付方式、最终用户和地区进行细分。

根据组件，市场分为三类：软体、服务和硬体。软体引领远距癫痫市场，由人工智慧诊断工具、远端会诊平台和远端监控应用程式推动。接下来的服务包括远距医疗咨询、资料分析和个人化治疗计划。穿戴式脑电图设备和连接感测器等硬体支援资料收集，但市场份额较小。

根据技术，市场分为三类：即时（同步）、储存转发（非同步）和远端病人监控。即时（同步）技术主导远端癫痫市场，提供现场咨询和即时护理。接下来是储存转发（非同步），从而实现资料共享以供后期分析。远端病人监控正在不断发展，利用穿戴式装置和人工智慧驱动的洞察力来追踪癫痫发作模式并加强长期癫痫管理。

远程癫痫市场—地理洞察

从地理上看，远程癫痫市场呈现不同的采用率。北美凭藉先进的医疗基础设施和较高的数位素养而处于领先地位。在国家医疗保健计划的推动下，欧洲正迅速采用远距医疗解决方案。亚太地区呈现出巨大的成长潜力，尤其是网路存取不断扩大的城市地区。例如，澳洲政府投资了远距医疗基础设施，以改善偏远地区患者的医疗服务。在非洲，世界卫生组织 (WHO) 等组织的措施致力于利用行动技术提供基本医疗服务，包括癫痫管理。监管框架和医疗保健报销政策的地区差异也会影响市场成长。

远程癫痫市场-竞争格局：

远距癫痫治疗市场的竞争格局正在发生变化，既有成熟的医疗技术公司，也有创新新创公司。主要参与者包括提供远端监控设备、远距医疗平台和人工智慧诊断工具的参与者。例如，一家大型医疗设备公司和一家软体开发商之间的合作重点是将穿戴式感测器与基于云端的分析相结合，以实现即时癫痫发作监测。此外，一些新创公司正在开发行动应用程序，允许患者追踪癫痫发作、管理药物并远端联繫医疗保健提供者。美国国立卫生研究院 (NIH) 支持学术机构和产业合作伙伴之间的研究合作，以开发和验证新的远端癫痫技术。这种协作方式增强了创新，并促进了先进解决方案在临床实践中的应用。

最新动态：

2024 年 3 月，UCB SA 推出了 EpiNet 远距医疗平台，透过远距会诊和持续患者监测实现远距癫痫管理。这项创新增强了患者的参与度，提高了护理的可及性，并支持医疗保健提供者提供更有效率和个人化的治疗解决方案。

2024 年 6 月，Invitae 启动了「解锁癫痫背后的秘密」计划，为儿童癫痫患者提供价格合理的基因检测。该计划旨在缩短诊断时间、实现个人化护理并建立 Invitae 的罕见疾病资料库。基因方面的见解可以为制定个人化治疗提供参考，从而有可能减少或消除癫痫发作。

目录

第一章：远程癫痫市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 远程癫痫市场片段（按组件）
    • 远程癫痫市场（按技术）
    • 远程癫痫市场片段（按癫痫类型）
    • 远程癫痫市场片段（以交付方式）
    • 远程癫痫市场片段（按最终用户）
    • 远程癫痫市场（按国家/地区）
    • 远程癫痫市场（按地区）
  • 竞争洞察

第三章：远距癫痫治疗的主要市场趋势

  • 远程癫痫市场驱动因素
    • 市场驱动因素的影响分析
  • 远程癫痫市场限制
    • 市场限制的影响分析
  • 远程癫痫市场机会
  • 远程癫痫市场未来趋势

第四章：远程癫痫产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：远程癫痫市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：远程癫痫市场格局

  • 2024年远程癫痫市场份额分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：远程癫痫市场－按组件

  • 概述
    • 按组件分類的细分市场占有率分析
    • 软体
      • 基于云端
      • 本地
    • 服务
      • 电话咨询服务
      • 远端监控和筛检服务
      • 远距教育与培训
      • 其他服务
    • 硬体

第 8 章：远程癫痫市场 - 按技术

  • 概述
    • 按技术细分的市场份额分析
    • 即时（同步）
    • 储存转发（非同步）
    • 远端病人监控

第九章：远程癫痫市场－依癫痫类型

  • 概述
    • 按癫痫类型分類的细分市场份额分析
    • 局部性癫痫
    • 全身性癫痫
    • 合併发作

第 10 章：远端癫痫市场 - 按交付方式

  • 概述
    • 按交付方式分類的细分市场份额分析
    • 基于网路
    • 基于云端
    • 本地部署

第 11 章：远程癫痫市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 专科诊所
    • 家庭护理设置
    • 研究机构

第 12 章：远程癫痫市场－依地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美远程癫痫主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按组件）
    • 北美市场规模和预测（按技术）
    • 北美市场规模及预测（按癫痫类型）
    • 北美市场规模及预测（以交付方式）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲远程癫痫主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按组成部分）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模及预测（按癫痫类型）
    • 欧洲市场规模及预测（以交付方式）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区远程癫痫主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（按组成部分）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区癫痫市场规模及预测（依癫痫类型）
    • 亚太地区市场规模及预测（以交付方式）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲远程癫痫主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按组成部分）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（按癫痫类型）
    • 拉丁美洲市场规模及预测（以交付方式）
    • LATAM 规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲远程癫痫主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按组成部分）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按癫痫类型）
    • 中东和非洲市场规模及预测（以交付方式）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 13 章：远程癫痫治疗产业主要供应商分析

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Allscripts Healthcare Solutions, Inc.
    • AMC Health
    • American Well Corporation
    • Cerner Corporation
    • Cisco Systems, Inc.
    • Doctor on Demand, Inc.
    • GE Healthcare
    • Iron Bow Technologies
    • LivaNova PLC
    • MDLive Inc.
    • Medtronic plc
    • Medvivo Group Ltd.
    • Philips Healthcare
    • Siemens Healthineers
    • Teladoc Health, Inc.
    • UCB SA
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4916

REPORT HIGHLIGHT

Tele-epilepsy Market size was valued at US$ 482.90 Million in 2024, expanding at a CAGR of 15.99% from 2025 to 2032.

The Tele-epilepsy Market addresses the delivery of epilepsy care remotely, leveraging technology to monitor and manage seizures. Driving factors include the increasing prevalence of epilepsy and the need for accessible healthcare, especially in underserved areas. The World Health Organization notes that epilepsy affects approximately 50 million people globally, making remote monitoring crucial. Restraints involve concerns over data security and the digital divide, limiting access for some patients. Market opportunities lie in the development of AI-driven seizure detection and remote patient monitoring platforms. For example, the National Institutes of Health (NIH) supports research into wearable sensors that can detect and predict seizures, enhancing remote care. This tech allows for timely intervention and improved patient outcomes.

Tele-epilepsy Market- Market Dynamics

Enhanced remote care access and AI-driven monitoring to accelerate Tele-epilepsy Market growth.

The Tele-epilepsy Market is seeing significant expansion, largely due to the rising adoption of digital health solutions. The Centers for Disease Control and Prevention (CDC) emphasizes the importance of remote patient monitoring for chronic conditions, including epilepsy, to improve patient outcomes. The Food and Drug Administration (FDA) has cleared several wearable devices for seizure detection, signaling a growing acceptance of technology in epilepsy management. For instance, the Veterans Health Administration (VHA) has piloted programs using telehealth platforms to provide neurological care to veterans with epilepsy, showing a reduction in travel time for patients by an estimated 30%. The National Institute of Neurological Disorders and Stroke (NINDS) supports research into AI algorithms that can analyze EEG data remotely, allowing for more timely and accurate diagnosis and management of seizures.

Tele-epilepsy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.99% over the forecast period (2025-2032)

Based on Component segmentation, Software was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Real-time (synchronous) was the leading Technology in 2024

Based on Epilepsy Type segmentation, Focal seizures were the leading Epilepsy Type in 2024

Based on Delivery Mode segmentation, Cloud-based was the leading Delivery Mode in 2024

Based on end user segmentation, Hospitals were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Tele-epilepsy Market- Segmentation Analysis:

The Global Tele-epilepsy Market is segmented on the basis of Component, Technology, Epilepsy Type, Delivery Mode, End User, and Region.

The market is divided into three categories based on Component: Software, Services, and Hardware. Software leads the tele-epilepsy market, driven by AI-powered diagnostic tools, teleconsultation platforms, and remote monitoring applications. Services follow, including telehealth consultations, data analysis, and personalized treatment plans. Hardware, such as wearable EEG devices and connected sensors, supports data collection but holds a smaller market share.

The market is divided into three categories based on Technology: Real-Time (Synchronous), Store and Forward (Asynchronous), and Remote Patient Monitoring. Real-time (synchronous) technology dominates the tele-epilepsy market, offering live consultations and immediate care. Store-and-forward (asynchronous) follows, enabling data sharing for later analysis. Remote patient monitoring is growing, leveraging wearable devices and AI-driven insights to track seizure patterns and enhance long-term epilepsy management.

Tele-epilepsy Market- Geographical Insights

Geographically, the Tele-epilepsy Market shows varied adoption rates. North America leads due to advanced healthcare infrastructure and high digital literacy. Europe is rapidly adopting telehealth solutions, driven by national healthcare initiatives. Asia-Pacific presents significant growth potential, particularly in urban areas with expanding internet access. For instance, the Australian government has invested in telehealth infrastructure to improve access for patients in remote areas. In Africa, initiatives by organizations like the World Health Organization (WHO) are focusing on leveraging mobile technology to deliver basic healthcare services, including epilepsy management. Regional variations in regulatory frameworks and healthcare reimbursement policies also influence market growth.

Tele-epilepsy Market- Competitive Landscape:

The Tele-epilepsy Market's competitive landscape is evolving, featuring a mix of established medical technology companies and innovative startups. Key players include those providing remote monitoring devices, telehealth platforms, and AI-driven diagnostic tools. For example, a partnership between a major medical device company and a software developer is focused on integrating wearable sensors with cloud-based analytics for real-time seizure monitoring. Also, several startups are developing mobile apps that allow patients to track seizures, manage medications, and connect with healthcare providers remotely. The National Institutes of Health (NIH) supports research collaborations between academic institutions and industry partners to develop and validate new tele-epilepsy technologies. This collaborative approach enhances innovation and facilitates the adoption of advanced solutions in clinical practice.

Recent Developments:

In March 2024, UCB S.A. launched the EpiNet Telehealth Platform, enabling remote epilepsy management through teleconsultation and continuous patient monitoring. This innovation enhances patient engagement, improves care accessibility, and supports healthcare providers in delivering more efficient and personalized treatment solutions.

In June 2024, Invitae launched its Unlock Behind the Seizure program, offering affordable genetic testing for pediatric epilepsy patients. The program aims to shorten diagnosis times, enable personalized care, and build Invitae's rare disease database. Genetic insights can inform tailored treatments, potentially reducing or eliminating seizures.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TELE-EPILEPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Allscripts Healthcare Solutions, Inc.
  • AMC Health
  • American Well Corporation
  • Cerner Corporation
  • Cisco Systems, Inc.
  • Doctor on Demand, Inc.
  • GE Healthcare
  • Iron Bow Technologies
  • LivaNova PLC
  • MDLive Inc.
  • Medtronic plc
  • Medvivo Group Ltd.
  • Philips Healthcare
  • Siemens Healthineers
  • Teladoc Health, Inc.
  • UCB S.A.
  • Others

GLOBAL TELE-EPILEPSY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Cloud-based
  • On-premises
  • Services
  • Tele-consultation services
  • Tele-monitoring and screening services
  • Tele-education & training
  • Other services
  • Hardware

GLOBAL TELE-EPILEPSY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Real-Time (Synchronous)
  • Store and Forward (Asynchronous)
  • Remote Patient Monitoring

GLOBAL TELE-EPILEPSY MARKET, BY EPILEPSY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Focal seizure
  • Generalized seizure
  • Combined seizure

GLOBAL TELE-EPILEPSY MARKET, BY DELIVERY MODE- MARKET ANALYSIS, 2019 - 2032

  • Web-Based
  • Cloud-Based
  • On-Premise

GLOBAL TELE-EPILEPSY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Research Institutions

GLOBAL TELE-EPILEPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Tele-epilepsy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Tele-epilepsy Market Snippet by Component
    • 2.1.2. Tele-epilepsy Market Snippet by Technology
    • 2.1.3. Tele-epilepsy Market Snippet by Epilepsy Type
    • 2.1.4. Tele-epilepsy Market Snippet by Delivery Mode
    • 2.1.5. Tele-epilepsy Market Snippet by End User
    • 2.1.6. Tele-epilepsy Market Snippet by Country
    • 2.1.7. Tele-epilepsy Market Snippet by Region
  • 2.2. Competitive Insights

3. Tele-epilepsy Key Market Trends

  • 3.1. Tele-epilepsy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Tele-epilepsy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Tele-epilepsy Market Opportunities
  • 3.4. Tele-epilepsy Market Future Trends

4. Tele-epilepsy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tele-epilepsy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Tele-epilepsy Market Landscape

  • 6.1. Tele-epilepsy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Tele-epilepsy Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Software
      • 7.1.2.1. Cloud-based
      • 7.1.2.2. On-premises
    • 7.1.3. Services
      • 7.1.3.1. Tele-consultation services
      • 7.1.3.2. Tele-monitoring and screening services
      • 7.1.3.3. Tele-education & training
      • 7.1.3.4. Other services
    • 7.1.4. Hardware

8. Tele-epilepsy Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Real-Time (Synchronous)
    • 8.1.3. Store and Forward (Asynchronous)
    • 8.1.4. Remote Patient Monitoring

9. Tele-epilepsy Market - By Epilepsy Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Epilepsy Type, 2024 & 2032 (%)
    • 9.1.2. Focal seizure
    • 9.1.3. Generalized seizure
    • 9.1.4. Combined seizure

10. Tele-epilepsy Market - By Delivery Mode

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Delivery Mode, 2024 & 2032 (%)
    • 10.1.2. Web-Based
    • 10.1.3. Cloud-Based
    • 10.1.4. On-Premise

11. Tele-epilepsy Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Specialty Clinics
    • 11.1.4. Homecare Settings
    • 11.1.5. Research Institutions

12. Tele-epilepsy Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Tele-epilepsy Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Tele-epilepsy Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Tele-epilepsy Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Tele-epilepsy Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Tele-epilepsy Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Epilepsy Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Tele-epilepsy Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Allscripts Healthcare Solutions, Inc.
    • 13.2.2. AMC Health
    • 13.2.3. American Well Corporation
    • 13.2.4. Cerner Corporation
    • 13.2.5. Cisco Systems, Inc.
    • 13.2.6. Doctor on Demand, Inc.
    • 13.2.7. GE Healthcare
    • 13.2.8. Iron Bow Technologies
    • 13.2.9. LivaNova PLC
    • 13.2.10. MDLive Inc.
    • 13.2.11. Medtronic plc
    • 13.2.12. Medvivo Group Ltd.
    • 13.2.13. Philips Healthcare
    • 13.2.14. Siemens Healthineers
    • 13.2.15. Teladoc Health, Inc.
    • 13.2.16. UCB S.A.
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us